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ABSTRACT

The independent versus joint effects of insulin and
thyroid hormone

protein
obese

(T3)

on soleus muscle glucose transport

(GLUT4) trafficking were assessed in diet-induced

(DIO)

insulin resistant rats, a model for type 2

diabetes mellitus. Wistar and Sprague-Dawley (SD)

compared after high-fat

(HF)

rats were

feeding during which Wistar

rats gained weight faster and achieved higher final body

weights than SD rats. Oral glucose tolerance tests revealed
insulin resistance in the Wistar rats and these animals
were subsequently given streptozotocin to block insulin
production followed by insulin injections at doses of 1

IU/kg BW to induce normoglycemia or a half dose of 0.5
IU/kg to mimic fasting serum insulin levels. Animals were

fed or fasted overnight to manipulate serum T3
concentrations.

Fasting lowered serum T3 in animals

receiving full insulin replacement but not in low insulin

dose animals.

GLUT4 concentrations were unchanged by

treatments which confirmed insulin resistance. However,
serum glucose concentrations were still reduced by the high

insulin dose indicating a persistent peripheral insulin

response. This study revealed a role for insulin in the
t
regulation of serum T3 that offers a novel pathway for
iii

integrating the daily insulin concentrations for the long
term regulation of skeletal muscle GLUT4 expression by T3.
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CHAPTER ONE
INTRODUCTION

Obesity and Type 2 Diabetes in the 21st Century
As this country enters the new millennium,

it faces a

precipitous rise in the rate obesity and its co-morbid
conditions.

Over the past two decades, the prevalence of

obesity in the United States has risen by about 50% and

shows no signs of abating

(Rippe et al,

2001).

The

prevalence and severity of obesity affects both men and
women and virtually all ethnic groups.

Childhood and

adolescent obesity also continues to rise rapidly (Troiano,

et al,

1995; NIH,

1996).

In a recent study by the

University of Southern California,

it was estimated that

the annual cost of 16-17 year-olds in hospitals due to

obesity has reached $127 million per year (Goran & Cruz,
2003).

An estimated 300,000 deaths annually are

attributable to obesity in the United States, thus ranking

obesity-related factors second only to smoking among the

leading causes of preventable death in adult Americans
(Rippe et al,

2001).

While it has been hotly debated whether this rising

problem with obesity is due to genetic or environmental

1

factors,

the scientific community has reached a consensus

that while genes make certain individuals more susceptible

than others, behavior has played a crucial role in the

population's attitude toward nutrition,
fitness,

exacerbating this epidemic.

obesity is, therefore,

of genetic,
al,

exercise and

The occurrence of

influenced by a complex interaction

environmental and behavioral factors

2001; Pi-Xunyer,

2002).

(Rippe et

The major difference in

lifestyle between now and forty years ago is the

disproportionately high intake of calorie-rich foods in the
absence of the required energy expenditure to burn the

excess fuel. These factors are compounded in individuals
who display the propensity for weight gain even though they

eat as much as another,

(McGarry, 2001).

less susceptible individual

The earlier stages of this type of

metabolic dysregulation is called Metabolic Syndrome X,

which occurs when an individual displays hyperinsulinemia
with concomitant hyperglycemia due to insulin resistance of

peripheral tissues like the liver and the skeletal muscle.

Type 2 diabetes mellitus occurs when pancreatic beta cell
failure takes place and the individual no longer
synthesizes or secretes endogenous insulin

(McGarry,

Type 2 diabetes has long been labeled as a disease of
2

2001).

inadequate glycemic control that is accompanied by obesity.
However,

it has recently come to light that defects in

fatty acid metabolism may be the actual cause of the
insulin resistance characteristic of type 2 diabetes,

strengthening the connection between obesity and insulin
resistance

(McGarry, 2001; Kuhlmann et al,

2003).

Lipids and Insulin Resistance
Dennis McGarry introduced a novel idea that lipid

accumulation inside the skeletal muscle, or

intramyocellular lipids

(IMCL), plays a major role in the

onset of insulin resistance and hyperglycemia
2003).

(McGarry,

While the exact mechanisms have yet to be

elucidated,

this hypothesis suggests a role for fatty acids

in the derangement of the regulatory pathways that control
everything from insulin transduction to transcription
factors in the skeletal muscle, adipocytes, vascular
endothelium and the liver

(D'Alessandro et al,

2000).

Because it is a critical site of glucose disposal, and
because it constitutes the greatest tissue mass,

skeletal

muscle is considered the main contributor to hyperglycemia

due to defective insulin-controlled glucose regulation
(Peterson & Shulman, 2002).

Individuals who are

3

predisposed to obesity have been found to have a decreased
capacity to oxidize fatty acids in their skeletal muscle

which leads to the accumulation of IMCL and the subsequent
inability of the muscle to respond to insulin signaling

(Kim et al,

1999; Tremblay et al, 2001).

Excess IMCL

accumulation prevents the muscle from taking up and
utilizing glucose through the normal pathways, thus leading

to its accumulation in the blood and subsequent

hyperglycemia

(Laybutt et al,

the muscle, therefore,
homeostasis.

1999) .

Insulin resistance in

is the root of defective glucose

Skeletal muscle insulin resistance becomes

further exacerbated by hepatic insulin resistance, which

causes excessive glucose release into the bloodstream
(Peterson & Shulman,

2002; Standaert et al,

2002). -

Glucose Homeostasis
Since the recent focus of diabetes research has been
on fat metabolism and how it affects a tissue's ability to

regulate glucose,

it is important to study the mechanism by

which glucose regulation takes place.

One such mechanism

addresses the means by which the hydrophilic glucose

molecule is able to cross cellular membranes. The chemical
nature of this molecule requires that it be transported
4

though the hydrophobic domain of membranes in order to pass

first into the cytoplasm by crossing the plasma membrane,
and then to different subcellular compartments by crossing

organellar membranes.

There are seven identified glucose transporter
proteins,

Different tissues have

GLUT1 through GLUT7.

characteristic expression patterns of glucose transporter
proteins that serve as controlled gates to take glucose in

and out of the cell depending on serum glucose
concentrations.

The skeletal muscle has GLUT4 proteins

that respond to insulin by increasing their numbers in the

plasma membrane

(Figure 1).

High serum glucose initiates

insulin secretion, which increases serum insulin

concentrations that act on the skeletal muscle insulin
receptors in order to stimulate GLUT4 translocation from
the cytoplasm to the cell membrane to take glucose out of

the blood,

and promoting storage as glycogen, thereby

lowering serum glucose levels

(Watson & Pessin,

2001).

When insulin resistance occurs, as in DM2, the insulin

signaling cascade fails to properly initiate normal
cellular responses due to the presence of excess lipids in
the skeletal muscle.

Under these circumstances GLUT4

proteins fail to translocate,

dock and fuse into the plasma

5

membrane thus preventing glucose uptake from the blood

et al,

2000; Dietz et al, 2002).

(Kim

This contributes to the

excess glucose accumulation in the serum and partially

explains the basis for hyperglycemia associated with type 2
diabetes mellitus.
In

vivo

NMR studies have shown glucose transport

across the plasma membrane by GLUT4 to be a key regulatory

a key

point in insulin-mediated muscle glycogen synthesis,

step in glucose uptake that limits glycogen synthesis

(Rothman,

2001).

Because increases in plasma free fatty

acid concentrations can reduce GLUT4 trafficking to the
plasma membrane, thereby inhibiting glucose transport, this

suggests that defects in fatty acid metabolism do indeed

have a key role in the pathogenesis of DM2 by interfering
with insulin activation of glucose transport into the

myocyte

(Peterson & Shulman, 2002).

Fasting and Nonfasting

In

Vivo

Metabolism

While McGarry's theory has been well-researched and
has gained support from the diabetes research community

(Peterson & Shulman, 2002), most of the studies concerning

fatty acid metabolism and glucose regulation have been done
using animals in the fasted state

6

(McGarry,

2001).

Because

fasting has profound and persistent effects on metabolism
and the hormones that regulate substrate-utilization,

it is

difficult to envision how results obtained from fasted

animals reflect the natural metabolic state of animals that
are obese due to chronic over-eating (Cettour-Rose et al,
2002).

In our own lab,

skeletal muscle from high-fat

(HF)

fed rats was found to be able to oxidize IMCL while
maintaining serum glycemia at the level of the lean

control-fed animals

(Jun & Fehn, 2003).

Two key

differences in our study and those of other investigators
were the use of non-fasted animals and the concurrent

analysis of both the extramyocellular lipids

(EMCL)

surrounding the myocyte and the IMCL deposits.

IMCL in

comparison to the EMCL revealed lipid influx into the IMCL

lipid stores. However, the results from similar studies

should be interpreted with caution and their methodology

closely examined because many of these studies have
measured total muscle lipids from whole muscle homogenates
rather than distinguishing EMCL and IMCL by morphological
analysis as was done in our lab.

In light of this

unexpected finding that the EMCL decreased in direct
proportion to rising IMCL levels, we concluded that it is

more likely that the skeletal muscle may,
7

in fact,

preferentially utilize lipids,
use glucose as a substrate.

rather than being unable to

This finding was also

confirmed through indirect calorimetry which showed that
the animals were utilizing lipids as their metabolic

substrate

(Jun & Fehn, 2003; Kelley & Mandarino,

2000).

The shift to lipid oxidation is proposed to reduce glucose
utilization,

thereby contributing to the elevation of serum

glucose concentrations that result from decreased disposal.
In a subsequent study we discovered that plasma membrane

GLUT4 concentrations in the skeletal muscle of the nonfasted obese animals were proportionate to the plasma
insulin levels

(Jun & Fehn, 2003)

indicating the

persistence of insulin responsiveness.

Our results stand

in sharp contrast to the dominant paradigm that insulin

resistance due to IMCL is the main pathology underlying
type 2 diabetes(McGarry, 2001; Jun et al,

2004).

The one

variable that has remained different in our studies in
comparison to others is the use of non-fasted subjects.

Nutrient Regulation by Leptin and Thyroid Hormone
A complete picture of the physiology that underlies

type 2 diabetes involves essentially every system in the

body.

The main theme throughout the study of this disease

8

is the dysfunctional trafficking of nutrients between

various synthetic and storage compartments such as the
liver,

adipose tissues, and the skeletal muscle

(Lewis et al, 2002; Fehn et al,

2002).

(Figure 2)

These compartments

are intricately regulated principally by the peripheral

sympathetic nervous system pathways that are under central
nervous system control at the hypothalamus

2000).

(Flier et al,

The main control center for appetite and satiety,

the hypothalamus,

metabolism.

is a key regulator of feeding and

It gains information about peripheral food

stores via nutrient-sensing pathways that involve hormonal

signaling through the leptin and thyroid hormone pathways
(Figure 3)

(Fehn et al, 2002; Flier et al,

2000).

Leptin is a hormone secreted in proportion to the

amount of fat stored in adipocytes and it regulates feeding

by acting as a nutrient level indicator for the brain.
While leptin has been thought of mainly as a satiety factor
or the stop signal for feeding,

it is more likely a "fuel

gauge," signaling the hypothalamus of lowered nutritional
status.

Leptin increases metabolism by stimulating

hypothalamic activity that is carried out through the

peripheral sympathetic neurons, particularly in the

skeletal muscle

(McGarry, 2001; Flier et al,
9

2000) .

Leptin

works closely with the thyroid hormone 3,5,3'

triiodothyronine

(T3)

in order to control the desire to eat

and to signal satiety stop when the individual

has

consumed sufficient quantities of food (Castello et al,
1994; Diano et al,

1998).

Because the hypothalamic

responses to leptin are conveyed to peripheral tissues

through sympathetic neurons, T3 can increase peripheral

responsiveness to leptin-regulated processes by enhancing
expression of (3-adrenergic receptors in target tissues like
the liver,
al,

adipose tissues and the skeletal muscle

1985; McGarry,

2001; Peterson & Shulman,

(Chu et

2002).

Thus,

there is a clear link between the regulation of metabolic

responses by leptin and their modulation by thyroid hormone

(Fehn et al, 2001; Fehn et al,

2002).

In as much as the

serum concentration of thyroid hormone is altered by
fasting,

this is but one source of potential error in

interpreting studies of metabolic regulation by leptin
using subjects with restricted food intake.
At the level of target tissues, T3 controls additional

response elements which must be taken into consideration

when evaluating metabolic regulation.

In addition to being

responsive to insulin, skeletal muscle GLUT4 protein
synthesis as well as trafficking are also stimulated by T3.
10

Thyroid hormone action on gene expression is mediated
primarily at the level of gene transcription and is most

prominent in the red muscle fiber types although thyroid
hormone stimulates GLUT4 expression in both red and white

skeletal muscle fiber types
Studies by Torrance et al

(Castello et al,

1994).

(1997) have demonstrated that

administration of T.3 was highly effective in augmenting

GLUT4 mRNA and protein expression in obese-insulin

resistance rat skeletal muscle of animals that were induced
into hypothyroidism prior to treatments.

This work points

out the potential for thyroid hormone mediated GLUT4
expression in insulin resistance when T3 is replaced to

correct a pathological hypothyroid state, but it failed to
test whether these actions are in effect under the

thyroidal status normally present in obese diabetic

subj ects.
The thyroid system is regulated at multiple levels,
one or more of which might account for nutritional
adaptation.

First, thyrotropin-releasing hormone

(TRH),

neuropeptide produced in the paraventricular nucleus
of the hypothalamus,

stimulating hormone

a

(PVN)

controls the release of thyroid(TSH)

from the pituitary.

TSH acts on

receptors on the thyroid to promote synthesis and release

11

of the inactive thyroid hormone T4 which is then converted

to T3 in peripheral tissues like the liver and kidney

(Figure 3)

(Flier et al,

2000; Silva et al,

T3 is

1982).

released post-prandially in order to increase metabolism
and promote lipolysis
1989)

(Wilcox et al,

1991; Hoppner & Seitz,

and probably hepatic lipogenesis.

In a lean

individual, T3 elicits skeletal muscle thermogenic activity
through the induction of uncoupling proteins

(UCPs)

for

non-shivering thermogenesis and stimulates GLUT4

trafficking to the skeletal muscle plasma membrane

(Ribiero

et al,

1997).

2001; Castello et al,

1994; Torrance et al,

Our lab has established that T3 reduces IMCL stores while
raising fatty acid metabolism in the skeletal muscle
et al, 2002; Goodridge et al,

2003).

(Fehn

This again

contradicts findings in the majority of the current

literature on diabetes research,

in which defective

skeletal muscle lipid oxidation is often cited as the root
of insulin resistance

1995).

(McGarry, 2001; Tremblay et al,

The practice of fasting, therefore, becomes even

more critical since the dramatic and persistent decline in

circulating T3 levels prior to treatment can affect

parameters such as whole-body metabolism, especially
glucose homeostasis and substrate utilization.

12

The goal of

this thesis was to address the potentially large role that

fasting could have in the obese, diabetic animal model and

their insulin sensitivity.
Current models of obesity and the development of type
2 DM have proposed that if an individual overeats,

that

he/she can eventually become insensitive to the satiety
signals that control appetite, thereby becoming obese and

perpetuating the oversecretion of hormones like insulin.

Such a dysregulation of nutrient intake can lead to excess

lipid accumulation in peripheral tissues that eventually
causes secondary defects in metabolism such as insulin
resistance
al,

2002) .

(McGarry, 2001; Tremblay et al,
Similarly,

2001; Hawkins et

chronic over-nutrition could promote

excessive thyroxine deiodination leading to chronic
elevations in serum T3.

Alternatively, peripheral

resistance to T3 may arise just as it has been theorized
that insulin resistance arises when tissues like the liver

and skeletal muscle fail to respond to elevated serum

insulin in the presence of excess fats
McGarry,

2001).

(Boden et al,

2001,

Physiological systems often see the loss

of regulation as a loss of the signal altogether.

Such a

sequence of events would lead to the accumulation of IMCL

and the development of insulin resistance that could
13

progress and develop into overt type 2 diabetes
(Chatterjee,

2001).

These are potential sequela that

warrant further attention if the normal progression toward

type 2 diabetes is to be understood.
It is well-established that the serum concentrations

of both insulin and thyroid hormone drop dramatically after

an overnight fast in non-obese animals, but these responses

have not been investigated simultaneously in the dietinduced obese-diabetic rat model

Diano et al,

1998).

(Byerley & Heber,

1996;

An overnight fast is a practice that

is standard in clinical and animal research studies.

This

method is known to cause a sharp drop in the level of T3,
mainly due to the lack of conversion from T4 to T3 by Type I

deiodinase

(Byerley,

1996; Fehn et al, 2001).

Since T3 is

an established stimulant of GLUT4 expression in the

skeletal muscle, the interpretation of results from
experiments that use fasted animals as their subjects may
be compromised

(Torrance et al,

1997).

The proposed work

sought to bridge this gap by characterizing the effects of

fasting on serum concentrations of insulin and T3 and GLUT4

trafficking in the skeletal muscle of high-fat diet induced
insulin resistant diabetic rats.

14

Purpose of the Thesis

This thesis project will investigate the effects of
fasting on the serum levels of two key regulatory hormones,
insulin and thyroid hormone

(T3)

and the effects of these

hormones on the trafficking of GLUT4 in soleus muscle.

From this it will be possible to characterize the ability
of T3 to independently stimulate GLUT4 trafficking in the

diet-induced obese-diabetic rat model.

Pilot Study on Hormone Interactions

In considering potential experimental designs, a pilot
project was done to determine whether T3 alters plasma
insulin concentration in the fasted state.

T3

administration during fasting restored plasma insulin

concentrations back to the levels of the non-fasted group.
In the group that was fasted and then given replacement T3,

their serum insulin and T3 values were
26.1 plU/ml and 81.8 + 15.8 ng/dl,

control animals were fed

ad

(mean+SEM)

respectively.

libitum.

93.2 +
The

Their serum insulin

and T3 values were 83.8 + 9.5 plU/ml and 86.4 + 17.3 ng/dl,

respectively.

Fasting with T3 replacement,

therefore,

could

not be used as an experimental manipulation to study

thyroid hormone-regulated skeletal muscle GLUT4 trafficking
15

in the presence of fasting concentrations of insulin

(Appendix B).

Independent versus Joint Effects of Insulin and T3
This study aims to evaluate the independent versus

joint effects of insulin and T3 on GLUT4 trafficking using a
novel approach to

in

vivo

metabolic manipulation.

Wistar

rats will be fed a high fat diet for 11 weeks to create
insulin-resistant, diet-induced obese
After insulin resistance is confirmed,

given streptozotocin (STZ)

(DIO)

animal models.

all animals will be

to stop endogenous insulin

secretion by the pancreatic beta cells, thereby allowing
the administration of replacement doses of insulin to mimic

serum insulin levels in animals that are either fasted
overnight or fed

ad

libitum

to modify endogenous T3

concentrations. Exogenous insulin administration will be
paired with normal serum T3 concentrations in animals
permitted to feed

ad

libitum

and with animals deprived of

food overnight to induce fasting concentrations of T3.

This

will provide four combinations of fed and fasting

concentrations of insulin and T3 from which to evaluate the
interaction of these hormones on soleus muscle GLUT4

16

transporter trafficking in a model of diet-induced insulin

resistance.

17

CHAPTER TWO
MATERIALS AND METHODS

Animals
Study 1
Male Sprague-Dawley rats

(Harlan Labs)

weighing 51-75

grams were housed in groups of 3-4 per cage and maintained
at 21-25°C,

14:10 hours light:dark (light 0600-2000h).

All

animals were fed a high-fat rodent chow with 45% of the
total kilocalories derived from fat

Food was available

ad

libitum

(Research Diets,

Inc.).

throughout the study.

Study 2

Male Wistar rats

(Charles River)

weighing 50-75 grams

were housed in groups of 3-4 per cage and maintained at 21-

14:10 hours light:dark (light 0600-2000h).

25°C,

All

animals were fed a high-fat rodent chow with 45% of the
total

kilocalories derived from fat

until they reached 17-19 weeks of age
ad

libitum

(Research Diets,

Inc.)

Food was available

until the experimental treatments began, when

the animals were either fasted or non-fasted, as described
below.
Prior to group assignment,

oral glucose tolerance test

each animal underwent an

(OGTT)

18

in order to confirm

impaired insulin sensitivity compared to non-diabetic
animals.

Animals were fasted for 16 hours and then given a

40% glucose solution

(Sigma Biochemical Co.) via an oral

gavage tube at a dose of lg glucose/kg body weight.

Blood

samples were collected by heel-stick using Safe-T Pro

Lancets

(Roche Pharmaceuticals).

Blood glucose values were

measured using Comfort Curve test strips in an Accu-Chek
glucose meter

(Roche Pharmaceuticals)

at 0,

30,

60,

90,

and

120 minutes following the oral glucose load.

Experimental Treatments
Study 1.
Diet-induced Obesity (DIO)
and Insulin Resistance in Response
to High Fat Feeding

Groups of 43 male SD and 32 male Wistar rats that were
provided high fat diet

(as described above) were subjected

to OGTT to confirm insulin resistance.

SD animals served

as high fat fed DIO animals refractory to induction of
insulin resistance and Wistar animals served as the DIO
responsive model.

The insulin resistant Wistar animals

were then employed for subsequent studies,
below.

19

as described

Study 2.
Interactive Effects of Insulin
and T3 on Soleus Muscle GLUT4 Trafficking Ablation of Pancreatic Beta Cells
and Insulin Secretion by
Streptozotocin (STZ)
Wistar rats having confirmed insulin resistance were

divided into respective treatment groups

(Table 1).

order to eliminate endogenous insulin production,

In

all

animals were fasted overnight and then received 80 mg/kg
body weight streptozotocin

(STZ,

Sigma Biochemical Co.).

The solution was prepared immediately before injection

mg/ml STZ in 0.05 M citrate,

(20

0.15 M NaCl, pH 4.5,).

Injections were administered intraperitoneally

(i.p.)

between 0800-0900h to induce type 1 diabetes as previously

described (Zhou,
injections,

2004).

Starting on the day after STZ

animals were provided with a 10% glucose

solution to prevent hypoglycemia resulting from attenuated

pancreatic alpha cell glucagon secretion that results from

insulin deficit

Type 1 diabetes was

(Zhou, 2004).

confirmed on the second day after the STZ injections using
blood from heel-sticks and the Accu-chek method,
described above.

All animals were given 1 unit

Humulin N insulin (Lilly Pharmaceuticals)

as

(U)

subcutaneously

into their lower backs in order to prevent diabetic

20

of

complications and loss of life due to hypoinsulinemia and
severe hyperglycemia.

Groups 1 and 2 served as the DIO fasted groups in

which serum T3 was reduced to the normal fasting
concentration which would be complemented by either a full

replacement dose of insulin (2 U) or a partial insulin dose
(1 U) of Humulin N

(Lilly Pharmaceuticals).

were provided food (not fasted)

Groups 3 and 4

in order to maintain normal

non-fasting serum T3 concentrations while being provided

either the full or partial replacement dose of Humulin N.

Tissue Collection

Animals were euthanized in a CO2 chamber which rendered

them anesthetized, unconscious, and led to ventilatory
arrest prior to death.

Upon cessation of ventilation but

prior to cardiac arrest approximately 1.0 ml of blood was

withdrawn via cardiac puncture using a 23 gauge needle and

a 1 ml syringe

(BD Medical Supplies). The blood was placed

on ice for approximately 15 minutes to allow clotting and

then centrifuged at l,000g for 10 minutes in order to

separate the serum from the whole blood cells.

Serum

samples were aliquoted into separate 1.5 ml eppendorf tubes
and stored in liquid nitrogen prior to RIA.
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Subsequent

bilateral thoracotomy and cardiac excision ensured that the
procedure was terminal. The entire soleus muscle from each
leg was collected from each animal and frozen in liquid

nitrogen for storage prior to assay.

In

Vivo

Metabolic Analyses

Prior to and during the treatments,

in

vivo

metabolic

rates of each animal were measured through indirect

calorimetry 10 minute•readings at 400 ml/min using a flow
through system (Ametek Model S-3A Oxygen Analyzer and Model

CD-SA Carbon Dioxide Analyzer)

in order to quantify the

amount of oxygen consumed and the carbon dioxide released
in respiratory gasses.

These measurements were used to

compute the respiratory quotient
consumed)

(RQ = ml CO2 released/ml O2

that reflects the type of fuel

(i.e.

fats,

carbohydrates or proteins) that the animals were utilizing

as their primary energy source

(Table 2). Baseline RQ

readings were measured prior to treatments and throughout
the 11-13 weeks of high-fat feeding.

Serum Hormone and Glucose Assays
Terminal point data include serum thyroid hormone
concentrations

(T3) ,

serum concentrations of insulin, blood
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glucose levels and GLUT4 protein concentrations in the
soleus muscle.

hormone

Serum concentrations of insulin and thyroid

(T3) were determined by commercial radioimmunoassay

(MP Biomedicals).

(RIA)

Serum glucose concentrations were

determined by the glucose oxidase colorimetric method

microassay (Sigma Biochemical Co.)

in a 96-well microtiter

plate read at 520 nm.

Soleus Muscle GLUT4 Quantification
Immediately following removal from liquid nitrogen,

0.10 g of soleus muscle was placed in 1 ml of ice-cold STM

buffer

(lOmM NaCl,

distilled water).

50mM Tris HC1 pH 8.0, and lOmM MgCl2 in

The mixture was homogenized on ice at

maximum speed (Con-Torque)
glass pestle.

for one minute using a ground

The homogenates were centrifuged at 4 °C at

14,000g for five minutes to separate cytoplasmic vesicles

containing GLUT4 from the plasma membrane GLUT4 fraction.
The supernatant

(cytoplasmic vesicular GLUT4 fraction) was

aliquoted into a fresh tube. The pellet
GLUT4 fraction)

(plasma membrane

was resuspended in 1 ml of ice-cold STM and

sonicated (Fisher Scientific Model 500 Sonic Dismembrator

with Ultrasonic Converter Model CL4)

at setting "5" for 30

seconds to remove the docked vesicles and fused GLUT4
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proteins from the plasma membranes.

The sonicated fraction

was centrifuged at 14,000g for 5 minutes at 4°C to separate

the GLUT4 from the vesicles and the membrane.

The

(now containing only the plasma membrane GLUT4

supernatant

protein fraction)

was aliquoted into a fresh 1.5 ml

microcentrifuge tube and the pellet discarded.

The protein

concentration in each homogenate was determined using the

Bradford Assay (BioRad).

Samples for subsequent analysis

were standardized to each contain 100 pg of total protein
and brought to 1000 pi with STM.

(Fraction V,

Bovine serum albumin

Pierce) was used to generate the standard

curve.
To each sample containing lOOpg of total protein,

5 pi of

diluted anti-GLUT4 primary antibody (5 pi primary antibody
in 45 pi STM)

GLUT4 antibody (GLUT4 rabbit polyclonal IgG,

Santa Cruz Biotech) were added and each sample was
vortexed.

The samples were incubated at 4 °C overnight to

allow binding of primary antibody to GLUT4 proteins.
20 pi Protein A-Agarose

(Santa Cruz Biochemicals)

added to each sample and each sample was vortexed.

Then

were

The

samples were incubated at 4 °C overnight while rocking to
allow binding of the Protein-A Agarose to the primary
antibody.

Samples were then centrifuged at 14,000 g for 5
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minutes at 4 °C.

The supernatant was removed and the pellet

(0.137 M NaCl,

rinsed in 1 ml of ice-cold 1 x PBS
KC1,

0.00147 M KH2PO4,

autoclaved).

0.00801 M Na2HPO4 -7H20, pH 7.3,

Samples were rinsed, vortexed and centrifuged

a total of three times in PBS.

After the final rinse,

pi of lx Laemmli treatment buffer
2% SDS,

0.00268 M

10% Glycerol,

(0.0625M Tris HC1 pH 6.8,

5% 2 ((3) -mercaptoethanol)

the isolated GLUT4 pellet.
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was added to

The samples were stored at 4 °C

prior to gel electrophoresis.
The proteins were denatured by boiling for five minutes

in a water bath and 15 pi of each sample was loaded onto a
0.75mm thick,

12% single concentration Tris-Glycine gel for

electrophoresis

(Jules,

Inc.).

Additionally,

5 pi of

Molecular Weight Marker (Santa Cruz Biochemicals) were

loaded onto each gel containing the samples. The gels were
run for 40 minutes at 35 mA per gel

(Hoefer 'Scientific

instruments Mighty Small SE260; EC Apparatus Corp.

Power Source)

in Laemmli tank buffer

0.192 M Glycine,

EC-400

(0.025 M Tris, pH 8.3,

0.1% SDS) with a refrigerated water

circulator to maintain the temperature at 4 °C

(Cole Palmer

Model 1268-14).
The proteins were transferred (Hoefer Scientific
Instruments Model TE42) onto nitrocellulose
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(NC) membrane

(Osmonics)

M Tris,

at five amperes overnight in Towbin buffer

0.192 M Glycine, 20% methanol, pH 8.3).

(0.25

Success of

the transfer was confirmed by staining the gels with
Coomassie Brilliant Blue to ensure absence of any remaining
protein on the gel.
Blotto

The NC was blocked for 60 minutes in

(5% Carnation Dry Milk in Tris Buffered Saline -

20mM Tris,

500 mM NaCl, pH 7.5), and the second incubation

was carried out overnight at room temperature with shaking
in 20pl primary antibody (Santa Cruz Biotech, GLUT4 rabbit

polyclonal IgG)

diluted in 100 ml blotto.

This was

followed by three TBS rinses of five minutes each.

Then

the NC membrane was incubated overnight in 20pl secondary

antibody (Goat anti-rabbit IgG-HRP,

Santa Cruz) diluted in

100ml Blotto followed by three ten minute rinses in

TBS/0.05% Tween.

Lastly, the NC membrane was rinsed in TBS

once for five minutes.
Luminol Reagents A and B
0.125ml

Equal volumes of Western Blotting

(Santa Cruz Biochemical Co.)

using

(125 pi) per cm2 of NC was used to incubate the NC

for one minute.

Super RX,

The NC was exposed and the film (Fuji

8 x 10 in) developed' using a Mohr Enterprise

Model VP-200-ST film developer.

GLUT4 concentrations were

determined using NIH Image J software to obtain
uncalibrated optical densities

26

(OD)

of the bands visualized

using transmittance digital photograph images of the films
(UMAX Astra 1220U scanner).

Data Analyses

Statistical analyses were performed using SigmaStat
(Version 3.1).

Software
mean+SEM.

way

ANOVA

All data are expressed as

Strain weight gain data was analyzed using one
in order to compare between groups of animals of

varying ages.

The effects of feeding status and insulin on

serum hormone and blood glucose levels, glucose tolerance,

and PM GLUT4 concentrations were analyzed using two-way
ANOVA.

Tukey

post-hoc

analysis was used for multiple

comparisons in order to see which groups differed.

tables of critical values are listed in Appendix C.
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ANOVA

CHAPTER THREE

RESULTS

High-Fat Diet and Weight Gain
Growth curves for male Wistar and Spraque-Dawley rats

fed high-fat chow are shown in' Figure 4.
days, the Wistar animals gained,

In the first 28

on average,

305 g and

approximately 20-46 g/week thereafter, with maximal body

weights of 501.3+ 9.2 g being attained at 78-82 days of age

(DOA).

In comparison, the Sprague-Dawley rats

(SDs)

that

began the same diet at the same age required 145-159 days
to attain similar maximal weights of just under 500 g. The

Wistar rats showed an increased propensity for early weight

gain by attaining higher body weights by 78-82 DOA in

comparison with SDs at 145-159 DOA (501.3+9.2 v.

482.9 +

7.44 g, respectively; P< 0.001; Table 3).

In

In

vivo

Vivo

Metabolic Analyses

indirect calorimetry was performed on the

Wistar animals prior to and on the day of the STZ

injections in order to assess which type of fuel the
animals were metabolizing

(Figure 5). A progressive shift

toward higher RQ values as high-fat feeding continued
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indicates that the animals were increasing carbohydrate
utilization at the expense of lipid oxidation,

as is

typical of obese individuals developing insulin resistance
(Bray & Bouchard, 2004).

A drop in the RQ value on the

last set of readings corresponds to the day following an

overnight fast and injection of STZ in the previous

evening.

It should be noted that the values are slightly

above 1.0 probably due to moisture in the analyzers that

skewed the gas concentrations slightly.

Oral Glucose Tolerance Tests
All Wistar animals were confirmed to be insulin-

resistant after an OGTT demonstrated impaired glucose

tolerance following a 16h fast

(Figure 6).

The blood

glucose concentrations were increased by 60% at 60 minutes

following an oral glucose gavage and they remained elevated
at 90 and 120 minutes,

indicating a lack of glucose uptake

by normal target tissues.

In comparison, the non-resistant

Sprague-Dawley rats showed blood glucose restored to
baseline within 90 minutes of administering the glucose

challenge.

The blood glucose levels in the Wistar rats

were greater than those in the SD rats by approximately
11%,

14%, and 17% at 60,

90,

and 120 minutes,
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respectively

(P<0.05; Table 4). The Sprague-Dawley strain, which was

found to be non-resistant, experienced a full recovery at a

faster rate than the Wistar strain.

At 60 minutes after

the oral glucose load the serum glucose values of Wistar

rats were higher and this continued through 120 minutes

indicating insulin resistance.

It is interesting to note

that the SD rats actually began the OGTTs with higher

baseline fasting blood glucose levels at 0 minutes.

Insulin and Glucose Levels

. Serum T3,

In the presence of full doses of insulin (hi groups),
as would be present in fed animals,

fasting caused a

significant decrease in serum T3 concentrations

(p<0.01; Table 5).
significant

(p<0.05)

(Figure 7)

Interestingly, there was also a
decrease in serum T3 in the fed

(y)

animals, with lower levels seen in the animals given the
low

(lo)

dose of insulin, indicating possible interaction

of the two hormones

(Table 3).

in the fasted animals.

However, this was not seen

All animals given the lower dose of

insulin exhibited significantly reduced serum T3 levels,

suggesting that insulin may play a role in stimulating
peripheral deiodination rates that are responsible for T3
production.

Whether T3 and insulin act as antagonists to
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each other is also a possibility,

since each hormone has

opposite effects on nutrient metabolism, with T3 promoting

breakdown and insulin promoting storage.
Exogenous insulin administration resulted in higher

serum insulin levels

(Figure 8)

(P<0.05; Table 6)

in those

animals that received the full replacement dose of 2 IU and
lower serum levels in the animals that received the low

dose

(1 IU).

This verified that the treatments provided

the animals with the proper high and low serum insulin

concentrations that were specified in the treatment

protocol

(Figure 8).

The impact of the insulin-T3 treatment combinations on
serum glucose concentration is shown in Figure 9.

In the

presence of high serum insulin concentrations representing
a nonfasting state, a mild decrease in serum glucose was

observed.

All animals exhibited hyperglycemia, as would be

expected in the insulin-resistant,

DIO model. However,

the

animals that received high insulin doses did exhibit some
lowering of blood glucose levels when compared to the

groups that received low insulin doses, although the

difference was significant at a slightly lower confidence
limit

(p = 0.087; Table 7).
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Plasma Membrane GLUT4 Concentrations

GLUT4 concentrations were determined by Western blot
of immunoprecipitates from 100 pg plasma membrane total

protein from soleus muscle homogenates

(Figure 10).

Plasma

membrane GLUT4 concentrations did not differ between the
treatment groups

(Figure 11).

Although there were

significant differences in serum T3 and insulin levels due
to the treatments, muscle GLUT4 response exhibited little

change among the groups

(Figure 11), which is consistent

with insulin resistance

(Table 8). ■ The lack of response to

another direct regulator of GLUT4 trafficking, T3, may also

indicate T3 resistance at the peripheral target level of the

skeletal muscle in the DIO model.
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CHAPTER FOUR

DISCUSSION

This study was the first to elucidate in the diet-

induced obese

(DIO), diabetic animal model the joint versus

independent roles of two key hormones responsible for
nutrient homeostasis,

insulin and T3.

While much of the

research in type 2 diabetes has focused intently on the

roles of insulin and intramyocellular lipids on the
regulation of skeletal muscle glucose transporter protein
GLUT4,

the role of T3 on glucose homeostasis has not been

explored.

It has been established that T3 directly affects

GLUT4 trafficking to the plasma membrane as well as nuclear

events leading up to an increase in GLUT4 protein synthesis
(Castello et al,

1994; Torrance et al,

1997).

Fasting has

been shown to drastically reduce peripheral deiodination of

T4 to T3, but this is not taken into account during many,

not all,

if

of the studies done on animals or humans in the

fasted state

(Byerley & Heber,

has identified,

1996).

The current study

in DIO rats, changes in serum

concentrations of T3 that are modified by feeding status as
well as an insulin-dependence in T3 synthesis that is

present only in the nonfasting state
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(Figure 7). Additional

analyses demonstrated the impact of these hormones on
metabolic and nutrient trafficking responses.

These

findings underscore the importance of performing studies

under the correct feeding status when evaluating the
metabolic defects associated with insulin resistance and

diabetes.
In order to confirm insulin resistance and impaired

glucose uptake in the DIO Wistar rats, oral glucose
tolerance testing was used to compare Wistar rats after an

11-week HF diet to SD rats that had been on the same diet
for several months.

OGTT

When the two strains underwent the

(Figure 6), SDs showed no sign of impaired glucose

tolerance, unlike the Wistar rats that showed marked
impairment in glucose uptake with a prolonged recovery to

baseline after 120 minutes.

It is interesting to note that

these two strains reacted very differently to the same
diet, with the SDs remaining insulin-sensitive while the

Wistar rats developed Metabolic Syndrome X, and in a much
shorter time on the HF diet than the SDs.

A rather

startling discrepancy in the rate of weight gain between

the two strains was also observed (Figure 4).

Because

there are notable differences in both the development of

obesity and insulin resistance, usage of either strain for
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nutritional studies should be very carefully considered.
The differences in the genetic backgrounds of these two
particular strains also raise important and interesting
questions about the human population and an individual's
propensity toward becoming obese; not everyone who becomes
obese will become diabetic.

Clearly, genetic factors

should be taken into account when studying obesity and the
development of the Metabolic Syndrome as well as type 2

diabetes.
Concurrent with the weight gain in Wistar rats was a

shift in the nonfasting RQ values

(Figure 5)

indicating

increased carbohydrate utilization and decreased lipid
oxidation that typically accompanies the development of

obesity and insulin resistance

(Bray & Bouchard,

2004) .

Thus, HF feeding of Wistar rats induced a number of
physiological conditions that mimic major metabolic defects

that are observed in human obesity,

insulin resistance,

and

type 2 diabetes mellitus and provided a model with which to

address the impact of fasting on insulin-T3 interactions in

metabolic regulation.
The effects of fasting on whole-body metabolism were

observed in the initial phases of the study, when the RQ
values of the Wistar rats declined after a 12-hour fast
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(Figure 5). Clearly, this is not a benign effect,

showing a

short-term shift from carbohydrate utilization as a fuel
source toward more lipid oxidation which occurs as a result
of glucose-sparing mechanisms that are initiated during

fasting.

This itself has a significant impact not only on

metabolic substrate specificity in tissues, but also on the

animals' ability to make such a change under states of

malnourishment,

such as type 2 diabetes.

It supports

current research advocating calorie-restrictive diets in
order to induce weight loss and the clearance of excess
lipid depots from insulin-sensitive peripheral tissues like
the skeletal muscle, adipose depots and liver

al,

2000).

(Gazdag et

Fasting animals, therefore, could significantly

impact the findings from such studies and,

therefore,

these

results should be interpreted with caution.

One of the main goals of this study was to understand
how insulin and T3 worked to regulate nutritional

homeostasis,

first by finding how insulin,

in the presence.

or absence of food, regulated glucose metabolism.

establishing insulin resistance in the DIO model,

After

STZ

treatment eliminated endogenous insulin production and

allowed for the manipulation of serum insulin
concentrations independent of feeding and glycemic status.
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Concurrently,

serum T3 concentrations

(Figure 7)

were

manipulated through the normal fasting inhibition of
peripheral deiodination of T4.

Serum T3 was elevated in the

group that received.the full replacement dose of insulin

while being given food, which represented the control group
Interestingly, the animals that were fed

for this study.

and then given replacement or low doses of insulin
experienced a drop in serum T3 levels.

Insulin appears to

play a role in modulating non-fasting serum T3
concentration by regulating peripheral deiodination of T4 to
T3 in the nonfasted state.

It should be noted, however,

that this insulin effect on T3 levels was observed only in

those groups that were being fed

study.

ad

libitum

throughout the

This can be explained by the inhibition of 5'MDI

that already occurs with fasting (Byerley & Heber,

1996),

which would have masked any additional effect that insulin
may have had on peripheral deiodination,

the fed animals.

as was observed in

However, T3 was reduced by almost 50% in

all other remaining groups that were fasted the night
before termination,

including those receiving high doses of

insulin, which demonstrates the insulin-independent effect

of fasting on peripheral deiodination of T4 to T3

Heber,

1996).

(Byerley &

It appears that there is an interaction
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between insulin and T3 activity.

In this experiment,

fasting was shown to play an important role in the
inhibition of T3 synthesis while insulin played a secondary

role in maintaining serum T3 concentrations at normal
physiological levels under non-fasting conditions.

Serum insulin levels were also consistent with the
exogenous dosages that were given to each treatment group,
with both of the groups that received the full replacement
insulin doses exhibiting elevated levels of insulin in

comparison to the animals that received the half-dose of

insulin (Figure 8).

Although the decrease in serum glucose

levels in response to high insulin dose failed to reach a

statistical significance at P<0.05

(Figure 9),

it was

apparent that lower glucose levels occurred in the groups
that received the full replacement dose of insulin
(p=0.087),

and the elevated levels of glucose were seen in

the groups that received the lower dose of insulin.

All

subjects remained hyperglycemic in spite of the high serum
insulin levels and this is consistent with the DIO

phenotype that exhibits excessive glucose production by the

liver and impaired glucose uptake by the peripheral tissues
as a result of insulin resistance

(McGarry, 2001).

Thus,

the model performed according to expectations with respect
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to glucose intolerance due to attenuated insulin

responsiveness and provided the opportunity to investigate
the impact of insulin and feeding status on one of the key

skeletal muscle GLUT4

glucose trafficking controls,

transporter regulation.
The entry of glucose into cells is dependent upon the
insertion of glucose transport proteins into the plasma

membrane and attenuated insulin-stimulated GLUT4

trafficking in skeletal muscle is considered a major

contributor to the development of hyperglycemia in type 2
diabetes mellitus

(Boden et al,

Peterson & Shulman, 2002).

2001; Kelley et al,

2000;

But despite reports

demonstrating that T3 has the ability to induce GLUT4

synthesis and trafficking in the skeletal muscle in normal,
nondiabetic animals

1997),

(Castello et al,

1994; Torrance et al,

these responses have not been investigated in models

of DIO and insulin resistance.

It has been clearly established that peripheral

deiodination declines significantly and thereby reduces
serum T3 when animals are fasted, as evidenced through

literature
et al,

(Byerley et al,

1991)

1996; Diano et al,

1998; Wilcox

as well as the results of the current study.

Whether T3 acts upon GLUT4 trafficking synergistically with
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or independently from insulin was addressed by quantifying

soleus muscle plasma membrane GLUT4 under four insulin-T3

concentration combinations.

Despite treatment combinations

that exposed the soleus to high concentrations of both
insulin and T3, high concentrations of insulin with low

concentrations of T3, and low concentrations of both

hormones, there were no differences in plasma membrane
GLUT4 concentration between the control and treatment

groups.

Unexpectedly, the groups that were fed

ad

libitum

and received half-doses of insulin did not develop the

intended high concentrations of T3 with low insulin

concentrations

(Figure 7).

Since all of the subjects employed in this study were
insulin resistant DIO animals,

it is not surprising that

little or no change in GLUT4 trafficking was observed in

response to different insulin concentrations

(Figure 11).

However, the important finding here is that there appears

to be no fasting or feeding effect on plasma membrane GLUT4

concentrations,

this despite the substantial decreases in

serum T3 concentrations that accompany fasting.

The lack of any response to feeding or fasting raises
the possibility of parallel T3 resistance in these animals.

They were unable to respond to varying doses of insulin,
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a

known and potent stimulator of GLUT4 trafficking, and they
did not respond to changes in nutritional status as

reflected through serum T3, a hormone that affects GLUT4

synthesis as well as trafficking

(Torrance et al,

1997).

Although the mechanism by which T3 regulates GLUT4

trafficking is not yet clearly understood, this study

suggests the potential for T3 resistance in DIO animals that
is similar to insulin resistance.

A common subcellular

transduction pathway may be activated by T3 in the same

manner that insulin activates its downstream signaling

cascade, and excessive lipids could similarly be causing
blunted GLUT4 trafficking response to T3.

The animals that

received the full replacement dose of insulin while feeding
ad

libitum

had T3 'levels that were greater that any of the

other treatment groups

(Figure 7).

Yet this response was

not reflected in the plasma membrane GLUT4 concentrations,

nor was it observed in the animals that received high doses
of insulin while fasting

(Figure 11).

As a nuclear-acting hormone, T3 may act indirectly to

increase GLUT4 trafficking through its permissive role of
activating transcription factors that up-regulate insulin
receptor (IR) biosynthesis.

The increase in the number of

IR would increase the number of ligand-receptor
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interactions,

thereby stimulating more GLUT4 vesicular

translocation and docking into the plasma membrane.

If the

intracellular environment is overloaded with lipids,

there

is a strong possibility of compromised T3 uptake and/or
translocation into the nucleus.

Alternatively, the disconnection between feeding

status and its effect on GLUT4 trafficking may reflect the
typically slow action of the nuclear-acting T3 hormone.

Given that the animals were fed throughout the study and
only fasted overnight

(16h) prior to tissue collection,

the

T3-associated mechanisms may have persisted and therefore

not impacted the short-term regulation of GLUT4

trafficking.

This could suggest a role for T3 in the long

term regulation of insulin-responsiveness rather than in

short-term changes in feeding and nutritional status.

There is evidence from this study that insulin
influences deiodination of T4 to T3 in fed animals

7).

(Figure

Deiodination controls the amount of T3 that is present

in the blood, and T3 in turn controls the expression of

GLUT4 proteins in the myocytes

Therefore,

(Byerley & Heber,

1996).

it may be possible that while insulin, which

fluctuates with nutritional states over short periods of
time, acts as a short-term regulator of GLUT4 trafficking,
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T3 acts as a long-term set point in GLUT4 synthesis and

their availability within the cell.
In addition to affecting many of the same parameters

as insulin, T3 often affects them in opposite ways,

for

example, by promoting catabolism and release of stored
nutrients rather than their synthesis and storage.

It is

apparent that insulin and T3 may function variably as
synergists and antagonists depending upon the target tissue

and specific response.

Also,

like insulin,

serum T3 levels

rise in response to feeding and decline in lower

nutritional states,

so it is reasonable to hypothesize that

in the same manner that chronic hyperinsulinemia induces

insulin resistance, continuously elevated T3 levels may lead

to peripheral and/or central resistance to T3.

One can

speculate that this could then lead to a hypothyroid

phenotype which would include decreased beta oxidation,

increased gluconeogenesis,

and attenuated thermogenesis,

all of which would lead to insulin resistance,

a hallmark

of Metabolic Syndrome X.

T3 has antagonizing effects on many of the same

metabolic processes as insulin,

so this may also play a

large role in the dysfunctional nutrient homeostasis that
is seen in obese individuals

(Wilcox et al,
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1991).

Even

though T3 has been shown to play an active role in GLUT4
protein synthesis and trafficking,

its importance in the

study of obesity and type 2 diabetes has been put aside for
many years.

T3 affects virtually every process in nutrient

homeostasis including lipid metabolism and most

significantly, glucose homeostasis.

Since fluctuations in

T3 can occur from relatively minor changes in nutritional
status,

i.e. an overnight fast,

a practice that is standard

in nutrition studies, T3 deserves a closer look for its

ability as a potent nuclear transcriptional activator as
well as its direct effects on peripheral tissue metabolic
processes.

This thesis represents a unique approach to studying

the in vivo regulation of glucose homeostasis in the
insulin-resistant,

DIO animal model.

The question of how

insulin and T3 jointly or independently regulate GLUT4
glucose transporter trafficking has been addressed for the
first time in this study and the union of these hormonal
actions into a model has been proposed for the short- and

long-term regulation of GLUT4 transporters.

Further,

the

profound impact on metabolic substrate selection of fasting
subjects prior to collecting and interpreting data has been
demonstrated.

Studies into the nuclear transcriptional and
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protein synthetic events that follow fasting-induced T3

decline have yet to be undertaken in this obese,' diabetic
animal model and these will certainly offer an avenue of

discovery for a more comprehensive understanding of this

critical process in metabolic regulation.

Finally, unexpected differences in metabolic responses
between the two genetic strains of experimental animals,
Wistar and Sprague-Dawley, were reflective of some cases

that are currently seen with obese human populations, when
one overweight person ultimately develops type 2 diabetes.
while others do not ever develop any of its symptoms.

Therefore,

the choice of animal strains in specific studies

should be carefully considered and additional studies

designed to explore the genetic and physiological

differences between these two models with the hope of
better understanding the basis for metabolic variances in
humans.
Future studies in the onset of the nuclear
transcriptional and protein synthetic events that follow T3

decline after an overnight fast has yet to be studied in
the obese,

diabetic animal and is certainly an avenue that

should be further explored.
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APPENDIX A
FIGURES
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Figure 1.
Insulin-Stimulated GLUT4 Trafficking.
High serum glucose induces insulin secretion, which
stimulates GLUT4 translocation from the cytoplasm
to the cell membrane to enable glucose uptake from
the blood and activation of enzymes to affect
subsequent storage as glycogen, thereby lowering
serum glucose levels (Diagram was reproduced with
permission from Richard Fehn).
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Figure 2. Dysfunctional Nutrient Trafficking in Type
2 Diabetes.
Increased caloric intake and reduced
energy expenditure leads to an accumulation of TGs in
many tissues, especially adipose tissue,
which
causes FFA spillover to non-adipose tissue (dashed
lines indicate major sites of dysfunctional
trafficking).
The liver, pancreas, and especially
the skeletal muscle accumulate excess fats and
eventually develop the insulin resistance
characteristic of type 2 diabetes (Diagram was
reproduced with permission from Richard Fehn).
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Figure 3.
Hypothalamic Regulation of Metabolism.
The hypothalamus is the main feedback center for the
leptin signaling pathway through the arcuate nucleus.
A sufficient level of leptin is needed to stimulate
the paraventricular nucleus (PVN) to secrete
thyrotropin-releasing hormone (TRH).
TRH acts on the
pituitary to stimulate thyroid-stimulating hormone
(TSH).
TSH then acts on the thyroid to promote the
synthesis and release of thyroid hormones T4 and T3.
T3 is the inhibitory feedback signal to the pituitary
thyrotropes and PVN which stops TSH secretion
(Diagram was reproduced with permission from Richard
Fehn).
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Growth Curve: Sprague-Dawley Rats

Growth Curve: Wistar Rats

24-34

52-66

58-77

65-84

71-90

78-97

Days of Age (DOA)

Figure 4.
Wistar and Sprague-Dawley Growth Curves.
Growth curves while feeding on a 45% kcal by fat diet
over a period of a) 11.7 weeks for Wistar rats and b)
145-159 days for Sprague-Dawley rats.
In spite of a
longer period of feeding on the HF chow, the SD rats at
145-159 days of age remained significantly smaller than
Wistar rats at 78-97 days of age (p < 0.001).
Values
are mean+SEM, n=28-32.
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Wistar Rats’ Mean Respiratory Quotient

Figure 5.
The RQ of the Wistar rats increased
progressively with the development of obesity
as resistance developed and lipid metabolism
decreased.
A drop in RQ value indicating
increased lipid catabolism was observed
following an overnight fast and STZ injection
(84-98 Days).
Values are mean+SEM, n=32.
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OGTT Following a 16-Hour Fast

Figure 6.
Wistar rats showed significantly
impaired glucose tolerance in comparison to
nondiabetic SDs despite higher baseline
fasting glucose levels in the SDs (p<0.05).
Values are mean+SEM, n=28-32.
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Serum T3

Treatm ent G roups

Figure 7.
Serum T3 concentrations were
maintained at nonfasting levels in fed animals
that received the full replacement dose of
insulin (y/hi).
The serum T3 levels dropped
significantly (p<0.01) after fasting in the
animals that received the high doses of insulin
(n/hi).
This fasting effect was not observed
in the group that received lower doses of
insulin (n/lo).
The fed animals receiving low
insulin (y/lo) also had a drop in T3 (p<0.05).
All values are mean+SEM, n=7-8.
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Serum Insulin

Treatm ent 6 roups

Figure 8.
Exogenous insulin replacement with
high doses resulted in the higher serum insulin
levels seen in the n/hi and the y/hi groups.
The animals that received half doses, n/lo and
y/lo showed significantly lowered serum insulin
in comparison to the hi groups (p<0.05).
Values are mean+SEM, n=7-8.
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Serum Glucose

Figure 9.
Serum glucose levels were lowered
slightly in the high insulin dose groups in
comparison to the low insulin dosages, although only
to a statistical significance level of (p=0.087).
This lack of response indicates insulin resistance
in the DIO model.
Values are mean+SEM, n=7-8.
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Figure 10. Representative GLUT4 Protein Bands from
Each Treatment Group.
Representative Western blot
of GLUT4 protein bands were obtained from lOOpg of
soleus muscle plasma membrane total protein.
A MW
ladder is represented in the first column.
Treatment groups that were fed (y) or fasted (n)
and those receiving replacement (hi) or low (lo)
insulin doses are shown in columns 2-5.
GLUT4
proteins migrate at a position indicating a MW of
approximately 49.5 kDa (Arrow) (Ryder et al, 1999).
Values are mean+SEM, n=7-8.
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Plasma Membrane GLUT4 Concentrations

Figure 11. Plasma membrane GLUT4 content was
compared using densitometric scans of Western
blots.
None of the groups showed significant
changes in GLUT4 concentrations in response to
changing concentrations of insulin and T3
indicating resistance to both hormones with
respect to regulation of GLUT4 trafficking.
Values are mean+SEM, n=7-8.
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APPENDIX B
PILOT STUDY DATA
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Figure 1.
The control group (Vehicle:Non-fasted) was given
saline vehicle and fed ad libitum throughout the study.
Another group was fasted overnight (12 hours) and received
a replacement dose of T3 in order to compensate for the
decline in T3 that results due to decreased peripheral T4 to
T3 deiodination during starvation states like fasting
(T3:Faste.d) .
The serum insulin levels in the T3: Fasted
group appeared to have been restored to that of the control
group.
However, these results did not reach statistical
significance, probably due to the small sample numbers per
group (n = 5) which resulted in high within-group
variability.
In spite of the lack of statistically
significant differences between the control animals
(Vehicle:Non-Fasted) and the fasted animals given
replacement T3 (T3: Fasted) , it did appear that T3 may be
regulated by insulin to some degree.
It was concluded that
relying solely on fasting with exogenous T3 replacement in
order to control insulin and T3 levels independently of each
other would not be a sound approach.
Values are in
mean+SEM, n=5.
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Serum T3 Levels

Treatments:Feeding Status

Figure 2.
The serum T3 levels paralleled the insulin
concentrations and supported the possibility of interaction
between insulin and T3.
Values are in mean+SEM, n=5.
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APPENDIX C
TABLES
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Table 1.

Treatment Protocol for Study 2.

Treatment
Groups

n

Food

Insulin

Symbols

1

7

No

Low Dose of
Insulin

n/lo

2

8

No

Replacement
Dose of
Insulin

n/hi

3

7

Yes

Low Dose of
Insulin

y/lo

4

8

Yes

Replacement
Dose of
Insulin

y/hi

Table 2.
Respiratory quotient values under
varying substrate utilization conditions.
Substrate

RQ

Carbohydrates

1.00

Proteins

0.74

Lipids

0.71
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Table 3.
One-Way ANOVA - Comparing Body Weights Between
Two Strains at Different Ages

Source of
Variation

DF

Between Groups

SS

9

MS

F

7874325.324

874925.036
1417.272

Residual

312

442188.956

Total

321

8316514.280

P

617.330

<0.001

Table 4. Two-Way ANOVA - Testing the Effects of Time and
Strain on Glucose Tolerance

DF

Source of
Variation

SS

MS

F

P

Time

4

109669.522

27417.380

133.392

<0.001

Strain

1

23792.109

23792.109

115.754

<0.001

Time x
Strain

4

16088.188

4022.047

19.568

<0.001

Residual

350

71938.925

205.540

Total

359

222011.900

618.418
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Table 5. Two-Way ANOVA - Testing the Effects of Feeding and
Insulin on Serum T3 Levels
Source of
Variation
Feeding
Status
Insulin
Feeding
Status x
Insulin
Residual
Total

DF

SS

MS

F

P

1

2063.495

2063.495

5.699

0.025

1
1

.612.142
1216.011

612.142
1216.011

1.691
3.358

0.205
0.078

26
29

9414.200
13108.339

362.085
452.012

Table 6. Two-Way ANOVA - Testing the Effects of Feeding and
Insulin on Serum Insulin Levels
DF

Source of
Variation

SS

MS

F

P

Fed

1

140573.461

140573.461

4.502

0.039

Insulin

1

344880.339

344880.339

11.046

0.002

Fed x Insulin

1

271.288

271.288

0.00869

0.926

Residual

48 "

1498668.953

31222.270

Total

51

1939817.903

38035.645
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Table 7. Two-Way ANOVA - Testing the Effects of Feeding and
Insulin on Serum Glucose Levels

Source of
Variation
Feeding

DF

MS

SS

P

F

1

8119.737

8119.737

0.526

0.472

Insulin

1

47203.213

47203.213

3.057

0.087

Feeding x
Insulin
Residual

1

9890.832

9890.832

0.640

0.427

49

756726.444

15443.397

Total

52

832640.707

16012.321

Table 8. Two-Way ANOVA - Testing the Effects of Feeding
Status and Insulin on Plasma Membrane GLUT4 Concentrations

Source of
Variation

DF

SS

MS

F

P

Feeding
Status

1

0.00359

0.00359

0.575

0.454

Insulin
Feeding
Status x
Insulin

1
1

0.000132
0.00407

0.000132
0.00407

'0.0212
0.653

0.885
0.426

Residual
Total

28
31

0.175
0.183

0.00624
0.00589
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